Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women Using Depot Medroxyprogesterone Acetate (DMPA), Levonorgestrel (LNG) Implant, and Copper Intrauterine Devices (IUDs)

NCT02550067 is registered in ClinicalTrials.gov with FHI 360 as lead sponsor.

NCT NCT02550067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02550067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women Using Depot Medroxyprogesterone Acetate (DMPA), Levonorgestrel (LNG) Implant, and Copper Intrauterine Devices (IUDs)
Lead sponsor
FHI 360
Phase
Not applicable
Overall status
Completed
Start date
December 14, 2015
Completion date
October 31, 2018
Enrollment
7,830 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, hiv